Erasca Inc. Common Stock vs Navan Inc. Class A Common Stock — how do they compare? Erasca Inc. Common Stock trades at $15.57 (market cap $4.95B), while Navan Inc. Class A Common Stock trades at $23.16 (market cap $5.80B). The key difference: Navan Inc. Class A Common Stock is the larger of the two by market cap, and Erasca Inc. Common Stock is more actively traded (3,834,689 versus 3,022,922). Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and Navan Inc. Class A Common Stock for 0 Days on average.
| ERAS | NAVN | |
|---|---|---|
Market Cap | $4.95B | $5.80B |
Volume | 3,834,689 | 3,022,922 |
Sector | Health | Technology |
52-Week High | $22.47 | $30.58 |
52-Week Low | $2.20 | $8.51 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.72B | $5.15B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →